Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 23 - Issue 2 - February, 2011

Feature

Complex Case Intervention
Recurrent Coronary Artery Thrombus Formation in the Setting of Diabetic Ketoacidosis
01/28/2011
Aditya M. Sharma, MD*, James Wilks, MD*§, Herbert D. Aronow, MD, MPH*§
Aditya M. Sharma, MD*, James Wilks, ...
ABSTRACT: A 34-year-old male with insulin-dependent type II diabetes mellitus developed recurrent ST-elevation myocardial infarction in the setting of diabetic ketoacidosis. In both circumstances, coronary angiography revealed a large...
ABSTRACT: A 34-year-old male with insulin-dependent type II diabetes mellitus developed recurrent ST-elevation myocardial infarction in the setting of diabetic ketoacidosis. In both circumstances, coronary angiography revealed a large...
ABSTRACT: A 34-year-old male...
01/28/2011
Journal of Invasive Cardiology
Clinical Images
Coronary Acute Syndrome Due to a Large Occlusive Thrombus in an Aortosaphenous Vein Graft
01/27/2011
Vicens Martí, MD, Joan Garcia-Picart, MD, Antoni Serra, MD
Vicens Martí, MD, Joan Garcia-Picar...
A 74-year-old male was admitted for acute coronary syndrome. Seven years earlier he had undergone surgery for an abdominal aortic aneurysm and a venous graft bypass to the right coronary artery. At the present admission, the electrocardiogram...
A 74-year-old male was admitted for acute coronary syndrome. Seven years earlier he had undergone surgery for an abdominal aortic aneurysm and a venous graft bypass to the right coronary artery. At the present admission, the electrocardiogram...
A 74-year-old male was admitted...
01/27/2011
Journal of Invasive Cardiology
Original Contribution
Effect of Chronic Angiotensin Converting Enzyme Inhibitor Therapy on Myocardial Injury in Patients Undergoing Percutaneous Coronary Interventions
01/27/2011
Sumith Aleti, MD, Darpan Bansal, MD, Mayank Agrawal, MD, Barry F. Uretsky, MD, Rajesh Sachdeva, MD
Sumith Aleti, MD, Darpan Bansal, MD,...
ABSTRACT: Background. Procedural MI is a frequent complication of percutaneous coronary intervention (PCI). Angiotensin converting enzyme inhibitors (ACE-I) have been shown to reduce ischemic events in the setting of acute myocardial...
ABSTRACT: Background. Procedural MI is a frequent complication of percutaneous coronary intervention (PCI). Angiotensin converting enzyme inhibitors (ACE-I) have been shown to reduce ischemic events in the setting of acute myocardial...
ABSTRACT: Background. Procedural...
01/27/2011
Journal of Invasive Cardiology
Original Contribution
Relationship Between the Angiographically Derived SYNTAX Score and Outcomes in High-Risk Patients Undergoing Percutaneous Coronary Intervention
01/27/2011
Sorin J. Brener, MD, Ashok J. Prasad, MD, Raushan Abdula, MD, Terrence J. Sacchi, MD
Sorin J. Brener, MD, Ashok J. Prasad...
ABSTRACT: Numerous risk scores have been designed to predict the outcome of percutaneous coronary intervention (PCI). The Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score has been shown to...
ABSTRACT: Numerous risk scores have been designed to predict the outcome of percutaneous coronary intervention (PCI). The Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score has been shown to...
ABSTRACT: Numerous risk scores...
01/27/2011
Journal of Invasive Cardiology
Original Contribution
Angiographic and Clinical Characteristics of Patients with Acetylcholine-Induced Coronary Vasospasm on Follow-up Coronary Angiography Following Drug-Eluting Stent Implantation
01/27/2011
Shigenori Ito, MD, Kosuke Nakasuka, MD, Kotaro Morimoto, MD, Masahiko Inomata, MD, Takayuki Yoshida, MD, Nozomu Tamai, MD, Shin Suzuki, MD, Yoshimasa Murakami, MD, Akihiro Morino, CE*, Yoshiyuki Shimizu, CE*, Koichi Sato, MD
Shigenori Ito, MD, Kosuke Nakasuka, ...
ABSTRACT: Recent studies have shown that drug-eluting stents (DES) induce vascular endothelial dysfunction in both Cypher and Taxus stents. These studies evaluated coronary vasomotion in the peri-stent coronary segment for 1 lesion with 1...
ABSTRACT: Recent studies have shown that drug-eluting stents (DES) induce vascular endothelial dysfunction in both Cypher and Taxus stents. These studies evaluated coronary vasomotion in the peri-stent coronary segment for 1 lesion with 1...
ABSTRACT: Recent studies have...
01/27/2011
Journal of Invasive Cardiology
Tips and Techniques
Successful Fenestration Using a Chronic Total Occlusion-Dedicated Guidewire in a Patient with Catheter-Induced Dissection of the Right Coronary Artery
01/27/2011
Norimasa Taniguchi, MD, Akihiko Takahashi, MD, PhD, Shingo Sakamoto, MD
Norimasa Taniguchi, MD, Akihiko Taka...
ABSTRACT: Guiding catheter-induced coronary artery dissection is a rare, but hazardous complication of percutaneous coronary intervention (PCI) and is associated with the potential risk of impairment of coronary blood flow. Therefore,...
ABSTRACT: Guiding catheter-induced coronary artery dissection is a rare, but hazardous complication of percutaneous coronary intervention (PCI) and is associated with the potential risk of impairment of coronary blood flow. Therefore,...
ABSTRACT: Guiding...
01/27/2011
Journal of Invasive Cardiology
Tips and Techniques
Percutaneous Site-Specific Pharmacomechanical Thrombolysis-Thrombectomy System for Bilateral Acute Limb Ischemia
01/27/2011

Raghav Gupta, MD, Archana Gautam, MD, Thomas A. Hennebry, MB BCh BAO

Raghav Gupta, MD, Archana Gautam, MD,...
ABSTRACT: Acute limb ischemia (ALI) remains a life-threatening condition. Studies with catheter-directed thrombolysis and percutaneous mechanical thrombectomy systems show modest improvements in mortality compared to surgery but with pitfalls...
ABSTRACT: Acute limb ischemia (ALI) remains a life-threatening condition. Studies with catheter-directed thrombolysis and percutaneous mechanical thrombectomy systems show modest improvements in mortality compared to surgery but with pitfalls...
ABSTRACT: Acute limb ischemia...
01/27/2011
Journal of Invasive Cardiology
Spontaneous Coronary Artery Dissection: Case Series with Extended Follow Up
01/27/2011
Pranav Kansara, MD, MS* and Susan Graham, MD†
Pranav Kansara, MD, MS* and Susan Gra...
ABSTRACT: Spontaneous coronary artery dissection (SCAD) is atherosclerotic or non-atherosclerotic in origin. Eosinophilic infiltrate is identified in coronary artery adventitia in non-atherosclerotic SCAD. We postulate that a systemic...
ABSTRACT: Spontaneous coronary artery dissection (SCAD) is atherosclerotic or non-atherosclerotic in origin. Eosinophilic infiltrate is identified in coronary artery adventitia in non-atherosclerotic SCAD. We postulate that a systemic...
ABSTRACT: Spontaneous coronary...
01/27/2011
Journal of Invasive Cardiology

Insights

Commentary
Risk Scoring Systems for PCI: Does One Size Fit All?
01/27/2011
Holly L. Humphrey, MD and Robert J. Applegate, MD
Holly L. Humphrey, MD and Robert J. A...
Predicting outcomes in patients undergoing coronary revascularization has been a topic of long-standing interest. The ACC/AHA (American College of Cardiology/American Heart Association) lesion classification system devised in 1986 and revised...
Predicting outcomes in patients undergoing coronary revascularization has been a topic of long-standing interest. The ACC/AHA (American College of Cardiology/American Heart Association) lesion classification system devised in 1986 and revised...
Predicting outcomes in patients...
01/27/2011
Journal of Invasive Cardiology
Commentary
Resolute‚Ñ¢ Drug-Eluting Stent: A Resolution for Bifurcation Lesions?
01/27/2011
Rita Jermyn, MD and Luis Gruberg, MD
Rita Jermyn, MD and Luis Gruberg, MD ...
The treatment of coronary artery bifurcation lesions remains one of the most challenging lesion subsets in interventional cardiology because of a low success rate, a relatively high incidence of procedural complications, greater restenosis...
The treatment of coronary artery bifurcation lesions remains one of the most challenging lesion subsets in interventional cardiology because of a low success rate, a relatively high incidence of procedural complications, greater restenosis...
The treatment of coronary artery...
01/27/2011
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

Transcatheter Heart Valves
LANDMARK Trial: Meril Announces Successful Primary Outcomes of Next-Gen Myval THV Series in Major RCT
05/17/2024

Meril Life Sciences News

Meril Life Sciences News
Professor Serruys, Chairman & study director of the LANDMARK trial, said, "Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating...
Professor Serruys, Chairman & study director of the LANDMARK trial, said, "Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating...
Professor Serruys, Chairman &...
05/17/2024
Cath Lab Digest
Heart Failure
Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
05/17/2024

Implicity News

Implicity News
SignalHF is unique in that the manufacturer-agnostic solution can be used to analyze data collected from a variety of CIEDs, including implantable cardiac defibrillators (ICD), pacemakers (PM) and cardiac resynchronization therapy devices...
SignalHF is unique in that the manufacturer-agnostic solution can be used to analyze data collected from a variety of CIEDs, including implantable cardiac defibrillators (ICD), pacemakers (PM) and cardiac resynchronization therapy devices...
SignalHF is unique in that the...
05/17/2024
Cath Lab Digest
Coronary Implants
DESyne BDS Plus RCT: Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World’s First Site-Specific Antithrombotic Therapeutic Compared to DES
05/16/2024

Elixir Medical News

Elixir Medical News
DESyne BDS Plus has a bioresorbable coating containing three drugs: two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor (sirolimus) designed for delivery of site-specific antithrombotic therapeutic.
DESyne BDS Plus has a bioresorbable coating containing three drugs: two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor (sirolimus) designed for delivery of site-specific antithrombotic therapeutic.
DESyne BDS Plus has a...
05/16/2024
Cath Lab Digest
Intravascular Lithotripsy
Primary Outcomes From PINNACLE I Clinical Trial Establish Safety and Effectiveness of Elixir Medical’s Hertz Contact IVL in Moderate to Severe Calcified Coronary Artery Lesions
05/16/2024

Elixir Medical News

Elixir Medical News
The novel LithiX Hertz Contact Intravascular Lithotripsy (IVL) system is designed to address challenges associated with the percutaneous treatment of nodular, concentric, and eccentric moderate to severe calcified lesions resistant to optimal...
The novel LithiX Hertz Contact Intravascular Lithotripsy (IVL) system is designed to address challenges associated with the percutaneous treatment of nodular, concentric, and eccentric moderate to severe calcified lesions resistant to optimal...
The novel LithiX Hertz Contact...
05/16/2024
Cath Lab Digest
Bioadaptors
BIOADAPTOR RCT Data Demonstrate Significant Clinical Advantage of Elixir Medical’s DynamX Bioadaptor Over Standard of Care Drug-Eluting Stent at Two Years
05/16/2024

Elixir Medical News

Elixir Medical News
Elixir Medical announced two-year results from the BIOADAPTOR randomized controlled (1:1) trial, comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute Onyx™ Drug-Eluting Stent from 34 centers in Japan, Europe, and New...
Elixir Medical announced two-year results from the BIOADAPTOR randomized controlled (1:1) trial, comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute Onyx™ Drug-Eluting Stent from 34 centers in Japan, Europe, and New...
Elixir Medical announced...
05/16/2024
Cath Lab Digest
Intravascular Lithotripsy
FastWave Medical Granted Fifth Utility Patent Reflecting Continuous Expansion of IVL IP Portfolio
05/16/2024

FastWave Medical News

FastWave Medical News
The newly granted patent bolsters the innovative design of FastWave's next-generation IVL platform, aimed at overcoming challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The newly granted patent bolsters the innovative design of FastWave's next-generation IVL platform, aimed at overcoming challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The newly granted patent...
05/16/2024
Cath Lab Digest
IMAGING
One in Three People Die Due to Atherosclerosis: A New Initiative, REACT, Aims to Find New Ways to Prevent It
05/16/2024

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) News

Centro Nacional de Investigaciones Ca...
“REACT will develop – at scale - methods to directly visualize the disease (atherosclerosis),” says Dr. Borja Ibáñez, Scientific Director of CNIC, cardiologist at Fundación Jiménez Díaz hospital, and leader of the Spanish part of the study.
“REACT will develop – at scale - methods to directly visualize the disease (atherosclerosis),” says Dr. Borja Ibáñez, Scientific Director of CNIC, cardiologist at Fundación Jiménez Díaz hospital, and leader of the Spanish part of the study.
“REACT will develop – at scale -...
05/16/2024
Cath Lab Digest
hypertension
Patient “Chronotype” Could Impact Best Time to Take Blood Pressure Medication
05/16/2024

University of Dundee News

University of Dundee News
Scientists observed that so-called “morning larks” (earlier chronotypes) who took their prescribed blood pressure medication in the morning were less likely to experience a heart attack than those who were “misaligned” and took it in the...
Scientists observed that so-called “morning larks” (earlier chronotypes) who took their prescribed blood pressure medication in the morning were less likely to experience a heart attack than those who were “misaligned” and took it in the...
Scientists observed that...
05/16/2024
Cath Lab Digest
Extreme exercise
JAMA: Exercise Does Not Accelerate Artery Plaque Buildup More Often Seen in Fitness Enthusiasts
05/16/2024

UT Southwestern Medical Center News

UT Southwestern Medical Center News ...
The study, which analyzed more than 8,700 participants from 1998-2019, provides important insight on whether people whose heart scans detect higher calcium should modify their exercise regimen to slow the plaque buildup in arteries.
The study, which analyzed more than 8,700 participants from 1998-2019, provides important insight on whether people whose heart scans detect higher calcium should modify their exercise regimen to slow the plaque buildup in arteries.
The study, which analyzed more...
05/16/2024
Cath Lab Digest
Pregnancy
Infertility Treatment Doubles Risk of Postpartum Heart Disease
05/15/2024

Rutgers University News

Rutgers University News
“We have been involved in a series of studies over the past few years that have found serious risks of heart disease and stroke to various high-risk patient populations within those initial 30 days after delivery – risks that could be...
“We have been involved in a series of studies over the past few years that have found serious risks of heart disease and stroke to various high-risk patient populations within those initial 30 days after delivery – risks that could be...
“We have been involved in a...
05/15/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Transcatheter Heart Valves
LANDMARK Trial: Meril Announces Successful Primary Outcomes of Next-Gen Myval THV Series in Major RCT
05/17/2024

Meril Life Sciences News

Meril Life Sciences News
Professor Serruys, Chairman & study director of the LANDMARK trial, said, "Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating...
Professor Serruys, Chairman & study director of the LANDMARK trial, said, "Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating...
Professor Serruys, Chairman &...
05/17/2024
Cath Lab Digest
Heart Failure
Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
05/17/2024

Implicity News

Implicity News
SignalHF is unique in that the manufacturer-agnostic solution can be used to analyze data collected from a variety of CIEDs, including implantable cardiac defibrillators (ICD), pacemakers (PM) and cardiac resynchronization therapy devices...
SignalHF is unique in that the manufacturer-agnostic solution can be used to analyze data collected from a variety of CIEDs, including implantable cardiac defibrillators (ICD), pacemakers (PM) and cardiac resynchronization therapy devices...
SignalHF is unique in that the...
05/17/2024
Cath Lab Digest
Coronary Implants
DESyne BDS Plus RCT: Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World’s First Site-Specific Antithrombotic Therapeutic Compared to DES
05/16/2024

Elixir Medical News

Elixir Medical News
DESyne BDS Plus has a bioresorbable coating containing three drugs: two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor (sirolimus) designed for delivery of site-specific antithrombotic therapeutic.
DESyne BDS Plus has a bioresorbable coating containing three drugs: two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor (sirolimus) designed for delivery of site-specific antithrombotic therapeutic.
DESyne BDS Plus has a...
05/16/2024
Cath Lab Digest
Intravascular Lithotripsy
Primary Outcomes From PINNACLE I Clinical Trial Establish Safety and Effectiveness of Elixir Medical’s Hertz Contact IVL in Moderate to Severe Calcified Coronary Artery Lesions
05/16/2024

Elixir Medical News

Elixir Medical News
The novel LithiX Hertz Contact Intravascular Lithotripsy (IVL) system is designed to address challenges associated with the percutaneous treatment of nodular, concentric, and eccentric moderate to severe calcified lesions resistant to optimal...
The novel LithiX Hertz Contact Intravascular Lithotripsy (IVL) system is designed to address challenges associated with the percutaneous treatment of nodular, concentric, and eccentric moderate to severe calcified lesions resistant to optimal...
The novel LithiX Hertz Contact...
05/16/2024
Cath Lab Digest
Bioadaptors
BIOADAPTOR RCT Data Demonstrate Significant Clinical Advantage of Elixir Medical’s DynamX Bioadaptor Over Standard of Care Drug-Eluting Stent at Two Years
05/16/2024

Elixir Medical News

Elixir Medical News
Elixir Medical announced two-year results from the BIOADAPTOR randomized controlled (1:1) trial, comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute Onyx™ Drug-Eluting Stent from 34 centers in Japan, Europe, and New...
Elixir Medical announced two-year results from the BIOADAPTOR randomized controlled (1:1) trial, comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute Onyx™ Drug-Eluting Stent from 34 centers in Japan, Europe, and New...
Elixir Medical announced...
05/16/2024
Cath Lab Digest
Intravascular Lithotripsy
FastWave Medical Granted Fifth Utility Patent Reflecting Continuous Expansion of IVL IP Portfolio
05/16/2024

FastWave Medical News

FastWave Medical News
The newly granted patent bolsters the innovative design of FastWave's next-generation IVL platform, aimed at overcoming challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The newly granted patent bolsters the innovative design of FastWave's next-generation IVL platform, aimed at overcoming challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The newly granted patent...
05/16/2024
Cath Lab Digest
IMAGING
One in Three People Die Due to Atherosclerosis: A New Initiative, REACT, Aims to Find New Ways to Prevent It
05/16/2024

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) News

Centro Nacional de Investigaciones Ca...
“REACT will develop – at scale - methods to directly visualize the disease (atherosclerosis),” says Dr. Borja Ibáñez, Scientific Director of CNIC, cardiologist at Fundación Jiménez Díaz hospital, and leader of the Spanish part of the study.
“REACT will develop – at scale - methods to directly visualize the disease (atherosclerosis),” says Dr. Borja Ibáñez, Scientific Director of CNIC, cardiologist at Fundación Jiménez Díaz hospital, and leader of the Spanish part of the study.
“REACT will develop – at scale -...
05/16/2024
Cath Lab Digest
hypertension
Patient “Chronotype” Could Impact Best Time to Take Blood Pressure Medication
05/16/2024

University of Dundee News

University of Dundee News
Scientists observed that so-called “morning larks” (earlier chronotypes) who took their prescribed blood pressure medication in the morning were less likely to experience a heart attack than those who were “misaligned” and took it in the...
Scientists observed that so-called “morning larks” (earlier chronotypes) who took their prescribed blood pressure medication in the morning were less likely to experience a heart attack than those who were “misaligned” and took it in the...
Scientists observed that...
05/16/2024
Cath Lab Digest
Extreme exercise
JAMA: Exercise Does Not Accelerate Artery Plaque Buildup More Often Seen in Fitness Enthusiasts
05/16/2024

UT Southwestern Medical Center News

UT Southwestern Medical Center News ...
The study, which analyzed more than 8,700 participants from 1998-2019, provides important insight on whether people whose heart scans detect higher calcium should modify their exercise regimen to slow the plaque buildup in arteries.
The study, which analyzed more than 8,700 participants from 1998-2019, provides important insight on whether people whose heart scans detect higher calcium should modify their exercise regimen to slow the plaque buildup in arteries.
The study, which analyzed more...
05/16/2024
Cath Lab Digest
Pregnancy
Infertility Treatment Doubles Risk of Postpartum Heart Disease
05/15/2024

Rutgers University News

Rutgers University News
“We have been involved in a series of studies over the past few years that have found serious risks of heart disease and stroke to various high-risk patient populations within those initial 30 days after delivery – risks that could be...
“We have been involved in a series of studies over the past few years that have found serious risks of heart disease and stroke to various high-risk patient populations within those initial 30 days after delivery – risks that could be...
“We have been involved in a...
05/15/2024
Cath Lab Digest

January 2011 Volume 23 Issue 2

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement